We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Application of Animal Models in Diabetic Cardiomyopathy.
- Authors
Wang-Soo Lee; Jaetaek Kim
- Abstract
Diabetic heart disease is a growing and important public health risk. Apart from the risk of coronary artery disease or hypertension, diabetes mellitus (DM) is a well-known risk factor for heart failure in the form of diabetic cardiomyopathy (DiaCM). Currently, DiaCM is defined as myocardial dysfunction in patients with DM in the absence of coronary artery disease and hypertension. The underlying pathomechanism of DiaCM is partially understood, but accumulating evidence suggests that metabolic derangements, oxidative stress, increased myocardial fibrosis and hypertrophy, inflammation, enhanced apoptosis, impaired intracellular calcium handling, activation of the renin-angiotensin-aldosterone system, mitochondrial dysfunction, and dysregulation of microRNAs, among other factors, are involved. Numerous animal models have been used to investigate the pathomechanisms of DiaCM. Despite some limitations, animal models for DiaCM have greatly advanced our understanding of pathomechanisms and have helped in the development of successful disease management strategies. In this review, we summarize the current pathomechanisms of DiaCM and provide animal models for DiaCM according to its pathomechanisms, which may contribute to broadening our understanding of the underlying mechanisms and facilitating the identification of possible new therapeutic targets.
- Subjects
DIABETIC cardiomyopathy; ANIMAL models in research; CARDIAC hypertrophy; RENIN-angiotensin system; HEART diseases; MUSCULAR hypertrophy
- Publication
Diabetes & Metabolism Journal, 2021, Vol 45, Issue 2, p129
- ISSN
2233-6079
- Publication type
Article
- DOI
10.4093/dmj.2020.0285